|
|
|
Company
Name |
Short
Summary |
| Abpro |
Abpro is focused on a proprietary technology platform that allows for faster, more efficient production of recombinant proteins and antibodies. |
| Agenus |
Agenus is focused on the research, development, and commercialization of vaccines and vaccine adjuvants. Agenus was formerly known as Antigenics. |
| Avaxia Biologics |
Avaxia Biologics is focused on the research and development of antibody products for diseases of the GI tract. |
| Concert Pharmaceuticals |
Concert Pharmaceuticals is focused on the research and development of novel drugs using deuterium instead of hydrogen which results in altered physiochemical and biological properties of the drug. |
| Cubist
Pharmaceuticals |
Cubist
Pharmaceuticals, Inc. is a drug company focused
on the discovery, development and commercialization
of novel drugs to treat infections. |
| Endo
Pharmaceuticals |
Endo
Pharmaceuticals is involved in the research, development,
comercialization and marketing of prescription pharmaceuticals
to treat and manage pain. |
| Microbia |
Microbia is focused on cost-effective bioprocesses using microbes for the production of chemicals from renewable materials. |
| Predictive Biosciences |
Predictive Biosciences is focused on the development and commercialization of diagnostics to direct cancer therapy. |
| Synageva |
Synageva is focused on the research and development of treatments for patients with rare diseases. |
| Synta Pharmaceuticals |
Synta Pharmaceuticals is focused on the discovery, research, and development of small molecule drugs with a focus on cancer and chronic inflammatory diseases. |
| Taris Biomedical |
Taris Biomedical is a focused on the research and development of therapeutics which take advantage of local sustained delivery of therapeutics to the genitourinary system. |
